Monday, 16 September 2024
  
Login

Australia's most trusted
source of pharma news

Monday, 16 September 2024
Ascott/Vivacity
Ascott/Vivacity
Latest News
List of PBS hopefuls swells to 20

Fifteen companies are in a strong position to secure government subsidy for 20 drugs next month, a Pharma in Focus analysis shows. See who's on the list.

GSK plots major market disruption
First ultra-long-acting asthma treatment heading to regulators
TODAY
Moderna switches to launch mode
R&D budget cut by $1.6B as focus moves to product launches
TODAY
Drug lands a month behind the US
Wins approvals as copycats target two blockbusters
TODAY Approvals Action
Most Popular
What's driving doctor prescribing?
The surprising influences behind which meds HCPs choose
13 September
Who's on the move with a new job?
Making a fresh start, moving on or moving up
13 September
New sales model for Aussie pharma
First direct-to-consumer platform connects patients and treatments
12 September
What's inside the HTA final report?
50 recommendations but any reform will be complex and costly
11 September
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (18)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (5)

Executive Roles (1)

Other (11)

More News
Introducing pharma's top KOLs
ICYMI: The stories that topped this week
13 September Your Week in Five Minutes
Footy greats talk clinical trials
Showcasing their lived experience and offering advice
13 September
Billion-dollar play to stay on top
Company looks to outdo itself with even better, safer treatments
13 September
TGA crackdown notches results
Oxycodone use drops by almost half in just one year
13 September
Meet the incoming RNA boss
Longstanding CEO of CAR T company jumps ship
12 September
Needle-free bird flu vax arrives
Clinical trial set to begin with US Govt backing
12 September
Industry legal eagles form network
Spearheaded by counsel from Novartis and the Cancer Council
12 September
Australia blind to cost of vision loss
Report finds eye disease costs the economy $1.8B a year
12 September
Cancer's 'low hanging fruit' ignored
Prevention should be simple but support is missing
12 September
Aussie obesity showdown begins
Lilly faces off with Novo after winning approval in red-hot market
11 September
Govt to safeguard precision meds
By banning adverse genetic test results in life insurance
11 September
When is it safe to jump ship?
How to assess if local biopharmas are too risky to join
11 September
Hunting for the edge in obesity
New delivery method could slash number of injections
11 September
Meet the drug that beat Keytruda
In historic first, world's biggest selling drug "decisively" defeated
10 September
PiF Jobs
PiF Jobs
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe